{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:51:58Z","timestamp":1795085518420,"version":"4.10.2"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004320","name":"Philips","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jcin.2019.10.059","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T16:01:14Z","timestamp":1581955274000},"page":"431-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["The IN.PACT DEEP Clinical Drug-Coated Balloon Trial"],"prefix":"10.1016","volume":"13","author":[{"given":"Thomas","family":"Zeller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Micari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dierk","family":"Scheinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bosiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank E.G.","family":"Vermassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Banyai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi H.","family":"Shishehbor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Brodmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dierk","family":"Scheinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Diehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Krankenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Sixt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bosiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Vermassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Brodmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Micari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Banyai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Lansink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Blessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2019.10.059_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/VHRM.S125065","article-title":"Critical limb ischemia: current challenges and future prospects","volume":"14","author":"Uccioli","year":"2018","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jcin.2019.10.059_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1586\/erd.11.67","article-title":"Below-the-knee drug-eluting stents and drug-coated balloons","volume":"9","author":"Karnabatidis","year":"2012","journal-title":"Expert Rev Med Devices"},{"issue":"Suppl S","key":"10.1016\/j.jcin.2019.10.059_bib3","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2019.10.059_bib4","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jacc.2016.02.040","article-title":"Nationwide trends of hospital admission and outcomes among critical limb ischemia patients: From 2003\u20132011","volume":"67","author":"Agarwal","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.10.059_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jvs.2004.11.041","article-title":"The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience","volume":"41","author":"Kudo","year":"2005","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2019.10.059_bib6","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.10.059_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2019.10.059_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1526602817745565","article-title":"Drug-coated balloon vs standard percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal arteries: one-year results of the MDT-2113 SFA Japan randomized trial","volume":"25","author":"Iida","year":"2018","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2019.10.059_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2019.10.059_bib10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease: Twelve-month outcomes from the randomized illumenate pivotal and pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2019.10.059_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2019.10.059_bib12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCULATIONAHA.113.001811","article-title":"Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia","volume":"128","author":"Liistro","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2019.10.059_bib13","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial","volume":"64","author":"Zeller","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.10.059_bib14","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.jcin.2015.07.011","volume":"8","author":"Zeller","year":"2015","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2019.10.059_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/1708538118759416","article-title":"Thirty-six-month outcomes of drug-eluting balloon angioplasty in the infrapopliteal arteries","volume":"26","author":"Ozpak","year":"2018","journal-title":"Vascular"},{"key":"10.1016\/j.jcin.2019.10.059_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1745-6215-15-63","article-title":"IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial","volume":"15","author":"Zeller","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.jcin.2019.10.059_bib17","series-title":"The Statistical Analysis of Failure Time Data","author":"Kalbfleisch","year":"1980"},{"key":"10.1016\/j.jcin.2019.10.059_bib18","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A\u00a0class of k-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.jcin.2019.10.059_bib19","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: A systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jcin.2019.10.059_bib20","series-title":"SAS\/Stat\u00ae 14.3 User\u2019s Guide: High-Performance Procedures","year":"2017"},{"key":"10.1016\/j.jcin.2019.10.059_bib21","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jvir.2017.08.003","article-title":"Endovascular interventions for femoropopliteal peripheral artery disease: a network meta-analysis of current technologies","volume":"28","author":"Jaff","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jcin.2019.10.059_bib22","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jacc.2016.04.071","article-title":"Critical limb ischemia: an expert statement","volume":"68","author":"Shishehbor","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.10.059_bib23","first-page":"664","article-title":"Drug-coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2-year results of the MDT-2113 SFA Japan randomized trial","volume":"93","author":"Iida","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2019.10.059_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the thunder trial","volume":"8","author":"Tepe","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2019.10.059_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007702","article-title":"Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions","volume":"12","author":"Laird","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2019.10.059_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2019.10.059_bib27","first-page":"124","article-title":"SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions","volume":"92","author":"Feldman","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2019.10.059_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/1526602816645080","article-title":"Single-center experience with Lutonix drug-coated balloons in infrapopliteal arteries","volume":"23","author":"Steiner","year":"2016","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2019.10.059_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.carrev.2017.06.006","article-title":"Drug-coated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia","volume":"19","author":"Palena","year":"2018","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jcin.2019.10.059_bib30","first-page":"232","article-title":"Lutonix\u00ae 014 DCB global below the knee registry study: interim 6-month outcomes","volume":"59","author":"Thieme","year":"2018","journal-title":"J\u00a0Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.jcin.2019.10.059_bib31","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/joic.12475","article-title":"Comparison of drug eluting balloon angioplasty to infrapopliteal artery critical lesions with or without additional pedal artery angioplasty in patients with diabetes mellitus and critical limb ischemia","volume":"31","author":"Teymen","year":"2018","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.jcin.2019.10.059_bib32","first-page":"1211","article-title":"Laser in Infrapopliteal and Popliteal Stenosis 2 Study (LIPS2): long-term outcomes of laser-assisted balloon angioplasty versus balloon angioplasty for below knee peripheral arterial disease","volume":"86","author":"Piyaskulkaew","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2019.10.059_bib33","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jvs.2012.10.109","article-title":"Outcomes following infrapopliteal angioplasty for critical limb ischemia","volume":"57","author":"Lo","year":"2013","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2019.10.059_bib34","article-title":"Long-term follow-up of the PADI trial: percutaneous transluminal angioplasty versus drug-eluting stents for infrapopliteal lesions in critical limb ischemia","volume":"6","author":"Spreen","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jcin.2019.10.059_bib35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jvs.2013.09.001","article-title":"Endovascular-first approach is not associated with worse amputation-free survival in appropriately selected patients with critical limb ischemia","volume":"59","author":"Garg","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2019.10.059_bib36","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jvs.2010.10.057","article-title":"Long-term outcomes of patients undergoing endovascular infrainguinal interventions with single-vessel peroneal artery runoff","volume":"53","author":"Abularrage","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2019.10.059_bib37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ejvs.2007.04.010","article-title":"Infrapopliteal composite bypass with autologous vein and second generation glutaraldehyde stabilized human umbilical vein (HUV) for critical lower limb ischaemia","volume":"34","author":"Neufang","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jcin.2019.10.059_bib38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0741-5214(91)90346-V","article-title":"Infrapopliteal bypass for severe ischemia: Comparison of autogenous vein, composite, and prosthetic grafts","volume":"13","author":"Londrey","year":"1991","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2019.10.059_bib39","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s00270-014-0904-3","article-title":"Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease","volume":"37","author":"Fanelli","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jcin.2019.10.059_bib40","first-page":"E212","article-title":"Peripheral arterial calcification: Prevalence, mechanism, detection, and clinical implications","volume":"83","author":"Rocha-Singh","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2019.10.059_bib42","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of survival with femoropopliteal artery revascularization with drug-coated devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcin.2019.10.059_bib43","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2019.01.013","article-title":"Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon","volume":"73","author":"Schneider","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.10.059_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1526602819857241","article-title":"Paclitaxel and mortality: the dose argument is critical","volume":"26","author":"Holden","year":"2019","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2019.10.059_bib45","first-page":"139","article-title":"Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: an updated meta-analysis of randomized controlled trials","volume":"94","author":"Anantha-Narayanan","year":"2019","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2019.10.059_bib46","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.jacc.2019.02.020","article-title":"Drug-eluting stent implantation and long-term survival following peripheral artery revascularization","volume":"73","author":"Secemsky","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.10.059_bib47","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00270-019-02194-w","article-title":"Two-year mortality after angioplasty of the femoro-popliteal artery with uncoated balloons and paclitaxel-coated balloons-a pooled analysis of four randomized controlled multicenter trials","volume":"42","author":"Albrecht","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jcin.2019.10.059_bib48","first-page":"205","article-title":"Drug-coated vs uncoated percutaneous transluminal angioplasty in infrapopliteal arteries: six-month results of the Lutonix BTK trial","volume":"31","author":"Mustapha","year":"2019","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jcin.2019.10.059_bib49","unstructured":"Guo W. New era for BTK: 6-month results from the China AcoArt II study. Paper presented at: Leipzig Interventional Course (LINC); 2019; Leipzig, Germany."},{"key":"10.1016\/j.jcin.2019.10.059_bib50","unstructured":"Giudice CD. Paclitaxel coated-balloon in below-the-knee lesions: 6-months results the Ranger BTK single center study. Paper presented at: Leipzig Interventional Course (LINC); 2019; Leipzig, Germany."},{"key":"10.1016\/j.jcin.2019.10.059_bib51","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/1526602818799736","article-title":"Three-year results of the absorb everolimus-eluting bioresorbable vascular scaffold in infrapopliteal arteries","volume":"25","author":"Varcoe","year":"2018","journal-title":"J\u00a0Endovasc Ther"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879819323970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879819323970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:11:19Z","timestamp":1761847879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879819323970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1936879819323970"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2019.10.059","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The IN.PACT DEEP Clinical Drug-Coated Balloon Trial","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2019.10.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}